IR
Superintel
OverviewMarketsWatchlist
© 2026 IR SuperintelMethodologyContact

Viking Therapeutics Inc

CUSIP: 92686JAA4 | 6 institutional holders

Quarters

Q3 2026
CompareDetailedHistoricalFundsOptionsShort Interest13D/13GPeersTargetingTrading SummaryProfile

Institutional Holders — Q3 2026

Context Capital Management, LLC40,000,000
0.8% of portfolio›$39.9M
Calamos Advisors LLC34,490,000
0.1% of portfolio›$35.1M
Advent Capital Management8,065,000
0.2% of portfolio›$8.0M
Jefferies Financial Group Inc.2,100,000
0.0% of portfolio›$2.1M
Monashee Investment Management LLC1,500,000
4.6% of portfolio›$1.5M
Calamos Wealth Management LLC102,000
0.0% of portfolio›$103.7K
StyleTurnoverLocationFiled
Context Capital Management, LLC
40,000,000$39.9M0.8%GrowthHighGreenwich, CT2026-11-04
Calamos Advisors LLC
34,490,000$35.1M0.1%CoreMediumNaperville, IL2026-11-02
Advent Capital Management
8,065,000$8.0M0.2%Deep ValueMediumNew York, NY2026-11-09
Jefferies Financial Group Inc.
2,100,000$2.1M0.0%CoreVery HighNew York, NY2026-11-05
Monashee Investment Management LLC
1,500,000$1.5M4.6%YieldVery HighBoston, MA2026-11-06
Calamos Wealth Management LLC
102,000$103.7K0.0%GrowthLowNaperville, IL2026-11-02